Transarterial Chemoembolization in the Coming Era of Decreased Reimbursement for Readmissions

Colin J. McCarthy, Andrew X. Zhu, Shehab A. Alansari, Rahmi Oklu

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: CMS has identified readmission of patients within 30 days of discharge as a targeted quality metric and has instituted financial penalties to encourage hospitals to reduce readmissions. The aims of this study were to examine the rate of 30-day admissions after transarterial chemoembolization (TACE) at a single institution and to identify potential factors associated with readmission. Methods: A total of 275 patients were identified who underwent a total of 457 TACE procedures over a 21-year period. Their electronic medical records were reviewed to evaluate the 30-day readmission rate in all patients undergoing TACE, and multiple logistic regression analysis was used to ascertain any clinical or demographic factors affecting the risk for readmission. Results: Nineteen patients (4.2%) required readmission to the hospital within 30 days; 11 of these readmissions were directly attributable to TACE, with inpatient stays upon readmission ranging from 2 to 27 days. Fourteen patients (3.1%) returned to the emergency department (ED) within 30 days of TACE. Medicare patients were more likely to be readmitted to the hospital or require emergency department treatment within 30 days than patients with private health insurance (P = .006). Patients with worse performance status (Eastern Cooperative Oncology Group) were also more likely to require emergency department care within 30 days (P = .04). Conclusions: TACE patients are at risk for readmission, often related to underlying medical comorbidities. Although extensively studied in other specialties, the Hospital Readmissions Reduction Program has received little attention in the radiology literature, and radiologists should familiarize themselves with this continually expanding initiative.

Original languageEnglish (US)
JournalJournal of the American College of Radiology
DOIs
StateAccepted/In press - 2016

Fingerprint

Patient Readmission
Hospital Emergency Service
Emergency Treatment
Electronic Health Records
Emergency Medical Services
Health Insurance
Medicare
Radiology
Comorbidity
Inpatients
Logistic Models
Regression Analysis
Demography

Keywords

  • Chemoembolization
  • Oncology
  • Readmissions
  • TACE
  • Transarterial

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Transarterial Chemoembolization in the Coming Era of Decreased Reimbursement for Readmissions. / McCarthy, Colin J.; Zhu, Andrew X.; Alansari, Shehab A.; Oklu, Rahmi.

In: Journal of the American College of Radiology, 2016.

Research output: Contribution to journalArticle

@article{338ed168af744c6f8bf43d63cacf9795,
title = "Transarterial Chemoembolization in the Coming Era of Decreased Reimbursement for Readmissions",
abstract = "Purpose: CMS has identified readmission of patients within 30 days of discharge as a targeted quality metric and has instituted financial penalties to encourage hospitals to reduce readmissions. The aims of this study were to examine the rate of 30-day admissions after transarterial chemoembolization (TACE) at a single institution and to identify potential factors associated with readmission. Methods: A total of 275 patients were identified who underwent a total of 457 TACE procedures over a 21-year period. Their electronic medical records were reviewed to evaluate the 30-day readmission rate in all patients undergoing TACE, and multiple logistic regression analysis was used to ascertain any clinical or demographic factors affecting the risk for readmission. Results: Nineteen patients (4.2{\%}) required readmission to the hospital within 30 days; 11 of these readmissions were directly attributable to TACE, with inpatient stays upon readmission ranging from 2 to 27 days. Fourteen patients (3.1{\%}) returned to the emergency department (ED) within 30 days of TACE. Medicare patients were more likely to be readmitted to the hospital or require emergency department treatment within 30 days than patients with private health insurance (P = .006). Patients with worse performance status (Eastern Cooperative Oncology Group) were also more likely to require emergency department care within 30 days (P = .04). Conclusions: TACE patients are at risk for readmission, often related to underlying medical comorbidities. Although extensively studied in other specialties, the Hospital Readmissions Reduction Program has received little attention in the radiology literature, and radiologists should familiarize themselves with this continually expanding initiative.",
keywords = "Chemoembolization, Oncology, Readmissions, TACE, Transarterial",
author = "McCarthy, {Colin J.} and Zhu, {Andrew X.} and Alansari, {Shehab A.} and Rahmi Oklu",
year = "2016",
doi = "10.1016/j.jacr.2016.04.030",
language = "English (US)",
journal = "JACR Journal of the American College of Radiology",
issn = "1558-349X",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Transarterial Chemoembolization in the Coming Era of Decreased Reimbursement for Readmissions

AU - McCarthy, Colin J.

AU - Zhu, Andrew X.

AU - Alansari, Shehab A.

AU - Oklu, Rahmi

PY - 2016

Y1 - 2016

N2 - Purpose: CMS has identified readmission of patients within 30 days of discharge as a targeted quality metric and has instituted financial penalties to encourage hospitals to reduce readmissions. The aims of this study were to examine the rate of 30-day admissions after transarterial chemoembolization (TACE) at a single institution and to identify potential factors associated with readmission. Methods: A total of 275 patients were identified who underwent a total of 457 TACE procedures over a 21-year period. Their electronic medical records were reviewed to evaluate the 30-day readmission rate in all patients undergoing TACE, and multiple logistic regression analysis was used to ascertain any clinical or demographic factors affecting the risk for readmission. Results: Nineteen patients (4.2%) required readmission to the hospital within 30 days; 11 of these readmissions were directly attributable to TACE, with inpatient stays upon readmission ranging from 2 to 27 days. Fourteen patients (3.1%) returned to the emergency department (ED) within 30 days of TACE. Medicare patients were more likely to be readmitted to the hospital or require emergency department treatment within 30 days than patients with private health insurance (P = .006). Patients with worse performance status (Eastern Cooperative Oncology Group) were also more likely to require emergency department care within 30 days (P = .04). Conclusions: TACE patients are at risk for readmission, often related to underlying medical comorbidities. Although extensively studied in other specialties, the Hospital Readmissions Reduction Program has received little attention in the radiology literature, and radiologists should familiarize themselves with this continually expanding initiative.

AB - Purpose: CMS has identified readmission of patients within 30 days of discharge as a targeted quality metric and has instituted financial penalties to encourage hospitals to reduce readmissions. The aims of this study were to examine the rate of 30-day admissions after transarterial chemoembolization (TACE) at a single institution and to identify potential factors associated with readmission. Methods: A total of 275 patients were identified who underwent a total of 457 TACE procedures over a 21-year period. Their electronic medical records were reviewed to evaluate the 30-day readmission rate in all patients undergoing TACE, and multiple logistic regression analysis was used to ascertain any clinical or demographic factors affecting the risk for readmission. Results: Nineteen patients (4.2%) required readmission to the hospital within 30 days; 11 of these readmissions were directly attributable to TACE, with inpatient stays upon readmission ranging from 2 to 27 days. Fourteen patients (3.1%) returned to the emergency department (ED) within 30 days of TACE. Medicare patients were more likely to be readmitted to the hospital or require emergency department treatment within 30 days than patients with private health insurance (P = .006). Patients with worse performance status (Eastern Cooperative Oncology Group) were also more likely to require emergency department care within 30 days (P = .04). Conclusions: TACE patients are at risk for readmission, often related to underlying medical comorbidities. Although extensively studied in other specialties, the Hospital Readmissions Reduction Program has received little attention in the radiology literature, and radiologists should familiarize themselves with this continually expanding initiative.

KW - Chemoembolization

KW - Oncology

KW - Readmissions

KW - TACE

KW - Transarterial

UR - http://www.scopus.com/inward/record.url?scp=84977532140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977532140&partnerID=8YFLogxK

U2 - 10.1016/j.jacr.2016.04.030

DO - 10.1016/j.jacr.2016.04.030

M3 - Article

C2 - 27325468

AN - SCOPUS:84977532140

JO - JACR Journal of the American College of Radiology

JF - JACR Journal of the American College of Radiology

SN - 1558-349X

ER -